Publications by authors named "A Nalan Azak"
Background: Immunoglobulin A (IgA) nephropathy (IgAN) treatment consists of maximal supportive care and, for high-risk individuals, immunosuppressive treatment (IST). There are conflicting results regarding IST. Therefore, we aimed to investigate IST results among IgAN patients in Turkiye.
View Article and Find Full Text PDFFollowing a 2015 ruling in the Turkish Supreme Court, vaccine resistance has increased significantly in Turkey. Where childhood vaccination was once compulsory, it is now voluntary, enabling the transformation of Turkish lay medical culture. This medical culture rose in political importance during the COVID-19 pandemic.
View Article and Find Full Text PDFArticle Synopsis
- The study aimed to compare clinical outcomes between peritoneal dialysis (PD) patients who had COVID-19 and a control group of PD patients without COVID-19, as there was limited data on this topic.
- The research involved 223 patients (113 with COVID-19 and 110 controls) and found that while general characteristics were similar, the COVID-19 group had lower serum albumin and hemoglobin levels and more complications like respiratory symptoms and rehospitalization on day 28.
- Over a 90-day period, mortality rates were low (1 death in the COVID-19 group), and although some health issues persisted for patients who had COVID-19, overall mortality did not significantly differ from the control group.
Introduction: We aimed to study the characteristics of peritoneal dialysis (PD) patients with coronavirus disease-19 (COVID-19), determine the short-term mortality and other medical complications, and delineate the factors associated with COVID-19 outcome.
Methods: In this multicenter national study, we included PD patients with confirmed COVID-19 from 27 centers. The baseline demographic, clinical, laboratory, and radiological data and outcomes at the end of the first month were recorded.
Purpose: Coronavirus disease 2019 (COVID-19) has a higher mortality in the presence of chronic kidney disease (CKD). However, there has not been much research in the literature concerning the outcomes of CKD patients in the post-COVID-19 period. We aimed to investigate the outcomes of CKD patients not receiving renal replacement therapy.
View Article and Find Full Text PDF